Login / Signup
Mid-Term Efficacy of Dupilumab in Children Aged≥36 Months to <12 Years With Atopic Dermatitis: A Case Series.
F J Melgosa Ramos
T Díaz Corpas
S Martín Jiménez
A Mateu Puchades
Published in:
Actas dermo-sifiliograficas (2024)
Keyphrases
</>
atopic dermatitis